nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—Myositis—Varenicline—nicotine dependence	0.0326	0.0453	CcSEcCtD
Losartan—Toothache—Varenicline—nicotine dependence	0.0262	0.0365	CcSEcCtD
Losartan—Glycosuria—Varenicline—nicotine dependence	0.0197	0.0274	CcSEcCtD
Losartan—Nocturia—Varenicline—nicotine dependence	0.0172	0.024	CcSEcCtD
Losartan—Musculoskeletal pain—Varenicline—nicotine dependence	0.0162	0.0225	CcSEcCtD
Losartan—UGT2B17—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0161	0.0572	CbGpPWpGaD
Losartan—Hyperkalaemia—Varenicline—nicotine dependence	0.0157	0.0218	CcSEcCtD
Losartan—UGT2B17—Biological oxidations—CYP2A7—nicotine dependence	0.0152	0.0539	CbGpPWpGaD
Losartan—UGT2B17—Metapathway biotransformation—CYP2A7—nicotine dependence	0.015	0.0532	CbGpPWpGaD
Losartan—Sleep disorder—Varenicline—nicotine dependence	0.0134	0.0186	CcSEcCtD
Losartan—Diabetes mellitus—Varenicline—nicotine dependence	0.0133	0.0186	CcSEcCtD
Losartan—Injury—Varenicline—nicotine dependence	0.0126	0.0176	CcSEcCtD
Losartan—Libido decreased—Varenicline—nicotine dependence	0.0125	0.0174	CcSEcCtD
Losartan—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0123	0.0435	CbGpPWpGaD
Losartan—Atrial fibrillation—Varenicline—nicotine dependence	0.0122	0.017	CcSEcCtD
Losartan—Arthritis—Varenicline—nicotine dependence	0.0119	0.0166	CcSEcCtD
Losartan—Hypoglycaemia—Varenicline—nicotine dependence	0.0119	0.0165	CcSEcCtD
Losartan—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.0115	0.016	CcSEcCtD
Losartan—Migraine—Varenicline—nicotine dependence	0.0114	0.0159	CcSEcCtD
Losartan—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0109	0.0388	CbGpPWpGaD
Losartan—Dry skin—Varenicline—nicotine dependence	0.0106	0.0148	CcSEcCtD
Losartan—Breast disorder—Varenicline—nicotine dependence	0.0105	0.0146	CcSEcCtD
Losartan—Cramp muscle—Varenicline—nicotine dependence	0.0104	0.0145	CcSEcCtD
Losartan—Gastritis—Varenicline—nicotine dependence	0.0103	0.0143	CcSEcCtD
Losartan—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00998	0.0354	CbGpPWpGaD
Losartan—UGT1A10—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00995	0.0353	CbGpPWpGaD
Losartan—Angina pectoris—Varenicline—nicotine dependence	0.00976	0.0136	CcSEcCtD
Losartan—Bronchitis—Varenicline—nicotine dependence	0.00964	0.0134	CcSEcCtD
Losartan—Pollakiuria—Varenicline—nicotine dependence	0.00926	0.0129	CcSEcCtD
Losartan—UGT1A10—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00925	0.0328	CbGpPWpGaD
Losartan—Erectile dysfunction—Varenicline—nicotine dependence	0.00923	0.0128	CcSEcCtD
Losartan—Photosensitivity reaction—Varenicline—nicotine dependence	0.00914	0.0127	CcSEcCtD
Losartan—Weight increased—Varenicline—nicotine dependence	0.00912	0.0127	CcSEcCtD
Losartan—Hyperglycaemia—Varenicline—nicotine dependence	0.00904	0.0126	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00886	0.0123	CcSEcCtD
Losartan—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00877	0.0311	CbGpPWpGaD
Losartan—Conjunctivitis—Varenicline—nicotine dependence	0.00868	0.0121	CcSEcCtD
Losartan—Epistaxis—Varenicline—nicotine dependence	0.00843	0.0117	CcSEcCtD
Losartan—Sinusitis—Varenicline—nicotine dependence	0.00838	0.0117	CcSEcCtD
Losartan—Hypoaesthesia—Varenicline—nicotine dependence	0.00798	0.0111	CcSEcCtD
Losartan—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.0076	0.027	CbGpPWpGaD
Losartan—Erythema multiforme—Varenicline—nicotine dependence	0.00758	0.0106	CcSEcCtD
Losartan—Tinnitus—Varenicline—nicotine dependence	0.00748	0.0104	CcSEcCtD
Losartan—Angiopathy—Varenicline—nicotine dependence	0.00728	0.0101	CcSEcCtD
Losartan—Arrhythmia—Varenicline—nicotine dependence	0.00716	0.00997	CcSEcCtD
Losartan—Erythema—Varenicline—nicotine dependence	0.00698	0.00972	CcSEcCtD
Losartan—Flatulence—Varenicline—nicotine dependence	0.00688	0.00958	CcSEcCtD
Losartan—Dysgeusia—Varenicline—nicotine dependence	0.00684	0.00952	CcSEcCtD
Losartan—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00678	0.0241	CbGpPWpGaD
Losartan—Back pain—Varenicline—nicotine dependence	0.00675	0.0094	CcSEcCtD
Losartan—Muscle spasms—Varenicline—nicotine dependence	0.00671	0.00934	CcSEcCtD
Losartan—Vision blurred—Varenicline—nicotine dependence	0.00658	0.00916	CcSEcCtD
Losartan—Tremor—Varenicline—nicotine dependence	0.00654	0.00911	CcSEcCtD
Losartan—Ill-defined disorder—Varenicline—nicotine dependence	0.00648	0.00902	CcSEcCtD
Losartan—Anaemia—Varenicline—nicotine dependence	0.00645	0.00898	CcSEcCtD
Losartan—Agitation—Varenicline—nicotine dependence	0.00642	0.00893	CcSEcCtD
Losartan—Angioedema—Varenicline—nicotine dependence	0.00638	0.00888	CcSEcCtD
Losartan—Malaise—Varenicline—nicotine dependence	0.0063	0.00876	CcSEcCtD
Losartan—Vertigo—Varenicline—nicotine dependence	0.00627	0.00873	CcSEcCtD
Losartan—Syncope—Varenicline—nicotine dependence	0.00626	0.00872	CcSEcCtD
Losartan—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00618	0.0219	CbGpPWpGaD
Losartan—Palpitations—Varenicline—nicotine dependence	0.00617	0.00859	CcSEcCtD
Losartan—Loss of consciousness—Varenicline—nicotine dependence	0.00614	0.00854	CcSEcCtD
Losartan—Cough—Varenicline—nicotine dependence	0.00609	0.00848	CcSEcCtD
Losartan—Arthralgia—Varenicline—nicotine dependence	0.00594	0.00827	CcSEcCtD
Losartan—Chest pain—Varenicline—nicotine dependence	0.00594	0.00827	CcSEcCtD
Losartan—Myalgia—Varenicline—nicotine dependence	0.00594	0.00827	CcSEcCtD
Losartan—Anxiety—Varenicline—nicotine dependence	0.00592	0.00825	CcSEcCtD
Losartan—Discomfort—Varenicline—nicotine dependence	0.00587	0.00818	CcSEcCtD
Losartan—Dry mouth—Varenicline—nicotine dependence	0.00581	0.00809	CcSEcCtD
Losartan—Oedema—Varenicline—nicotine dependence	0.0057	0.00793	CcSEcCtD
Losartan—Infection—Varenicline—nicotine dependence	0.00566	0.00788	CcSEcCtD
Losartan—Shock—Varenicline—nicotine dependence	0.00561	0.0078	CcSEcCtD
Losartan—Nervous system disorder—Varenicline—nicotine dependence	0.00559	0.00778	CcSEcCtD
Losartan—Thrombocytopenia—Varenicline—nicotine dependence	0.00558	0.00777	CcSEcCtD
Losartan—Tachycardia—Varenicline—nicotine dependence	0.00556	0.00774	CcSEcCtD
Losartan—Hyperhidrosis—Varenicline—nicotine dependence	0.00551	0.00767	CcSEcCtD
Losartan—Anorexia—Varenicline—nicotine dependence	0.00543	0.00756	CcSEcCtD
Losartan—Hypotension—Varenicline—nicotine dependence	0.00532	0.00741	CcSEcCtD
Losartan—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00528	0.0188	CbGpPWpGaD
Losartan—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00519	0.00723	CcSEcCtD
Losartan—AGTR1—Peptide GPCRs—OPRM1—nicotine dependence	0.00518	0.0184	CbGpPWpGaD
Losartan—Insomnia—Varenicline—nicotine dependence	0.00515	0.00717	CcSEcCtD
Losartan—Dyspnoea—Varenicline—nicotine dependence	0.00508	0.00707	CcSEcCtD
Losartan—Somnolence—Varenicline—nicotine dependence	0.00506	0.00705	CcSEcCtD
Losartan—Dyspepsia—Varenicline—nicotine dependence	0.00502	0.00698	CcSEcCtD
Losartan—Decreased appetite—Varenicline—nicotine dependence	0.00495	0.0069	CcSEcCtD
Losartan—Fatigue—Varenicline—nicotine dependence	0.00491	0.00684	CcSEcCtD
Losartan—Pain—Varenicline—nicotine dependence	0.00487	0.00678	CcSEcCtD
Losartan—Constipation—Varenicline—nicotine dependence	0.00487	0.00678	CcSEcCtD
Losartan—Feeling abnormal—Varenicline—nicotine dependence	0.00469	0.00654	CcSEcCtD
Losartan—Gastrointestinal pain—Varenicline—nicotine dependence	0.00466	0.00649	CcSEcCtD
Losartan—Urticaria—Varenicline—nicotine dependence	0.00453	0.0063	CcSEcCtD
Losartan—Abdominal pain—Varenicline—nicotine dependence	0.0045	0.00627	CcSEcCtD
Losartan—Body temperature increased—Varenicline—nicotine dependence	0.0045	0.00627	CcSEcCtD
Losartan—SLC2A9—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.0042	0.0149	CbGpPWpGaD
Losartan—Hypersensitivity—Varenicline—nicotine dependence	0.0042	0.00584	CcSEcCtD
Losartan—Asthenia—Varenicline—nicotine dependence	0.00409	0.00569	CcSEcCtD
Losartan—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00408	0.0145	CbGpPWpGaD
Losartan—Pruritus—Varenicline—nicotine dependence	0.00403	0.00561	CcSEcCtD
Losartan—UGT1A3—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00396	0.0141	CbGpPWpGaD
Losartan—Diarrhoea—Varenicline—nicotine dependence	0.0039	0.00543	CcSEcCtD
Losartan—SLC22A12—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00384	0.0136	CbGpPWpGaD
Losartan—Dizziness—Varenicline—nicotine dependence	0.00377	0.00525	CcSEcCtD
Losartan—UGT1A3—Biological oxidations—CYP2A7—nicotine dependence	0.00373	0.0133	CbGpPWpGaD
Losartan—UGT1A3—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00368	0.0131	CbGpPWpGaD
Losartan—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00364	0.0129	CbGpPWpGaD
Losartan—Vomiting—Varenicline—nicotine dependence	0.00362	0.00504	CcSEcCtD
Losartan—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00359	0.0128	CbGpPWpGaD
Losartan—Rash—Varenicline—nicotine dependence	0.00359	0.005	CcSEcCtD
Losartan—Dermatitis—Varenicline—nicotine dependence	0.00359	0.005	CcSEcCtD
Losartan—Headache—Varenicline—nicotine dependence	0.00357	0.00497	CcSEcCtD
Losartan—Nausea—Varenicline—nicotine dependence	0.00338	0.00471	CcSEcCtD
Losartan—UGT2B7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00337	0.012	CbGpPWpGaD
Losartan—UGT2B7—Biological oxidations—CYP2A7—nicotine dependence	0.00318	0.0113	CbGpPWpGaD
Losartan—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00316	0.0112	CbGpPWpGaD
Losartan—UGT2B7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00313	0.0111	CbGpPWpGaD
Losartan—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00311	0.0111	CbGpPWpGaD
Losartan—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00295	0.0105	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00295	0.0105	CbGpPWpGaD
Losartan—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00282	0.01	CbGpPWpGaD
Losartan—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00278	0.00986	CbGpPWpGaD
Losartan—UGT1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00274	0.00972	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—CYP2A7—nicotine dependence	0.0026	0.00922	CbGpPWpGaD
Losartan—UGT1A1—Biological oxidations—CYP2A7—nicotine dependence	0.00258	0.00916	CbGpPWpGaD
Losartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00257	0.00911	CbGpPWpGaD
Losartan—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00256	0.00908	CbGpPWpGaD
Losartan—UGT1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00254	0.00903	CbGpPWpGaD
Losartan—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00253	0.00899	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.00244	0.00865	CbGpPWpGaD
Losartan—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00228	0.0081	CbGpPWpGaD
Losartan—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00219	0.00779	CbGpPWpGaD
Losartan—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00217	0.00769	CbGpPWpGaD
Losartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00208	0.00739	CbGpPWpGaD
Losartan—AGTR1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00191	0.00677	CbGpPWpGaD
Losartan—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00178	0.00631	CbGpPWpGaD
Losartan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00169	0.00601	CbGpPWpGaD
Losartan—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00167	0.00593	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00167	0.00592	CbGpPWpGaD
Losartan—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00166	0.00591	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00163	0.0058	CbGpPWpGaD
Losartan—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00157	0.00557	CbGpPWpGaD
Losartan—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00155	0.00549	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00152	0.00538	CbGpPWpGaD
Losartan—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00144	0.00512	CbGpPWpGaD
Losartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00138	0.00489	CbGpPWpGaD
Losartan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00137	0.00487	CbGpPWpGaD
Losartan—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.00136	0.00482	CbGpPWpGaD
Losartan—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00134	0.00476	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—FGD1—nicotine dependence	0.00131	0.00465	CbGpPWpGaD
Losartan—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00129	0.00457	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00128	0.00456	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—OPRM1—nicotine dependence	0.00124	0.00442	CbGpPWpGaD
Losartan—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.00121	0.0043	CbGpPWpGaD
Losartan—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0012	0.00425	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—FGD1—nicotine dependence	0.00119	0.00422	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00118	0.00419	CbGpPWpGaD
Losartan—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00117	0.00416	CbGpPWpGaD
Losartan—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.00111	0.00392	CbGpPWpGaD
Losartan—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00109	0.00387	CbGpPWpGaD
Losartan—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.001	0.00356	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000949	0.00337	CbGpPWpGaD
Losartan—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000945	0.00335	CbGpPWpGaD
Losartan—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000932	0.00331	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—DRD2—nicotine dependence	0.0009	0.00319	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TAS2R16—nicotine dependence	0.000895	0.00318	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000863	0.00306	CbGpPWpGaD
Losartan—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000774	0.00275	CbGpPWpGaD
Losartan—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000729	0.00259	CbGpPWpGaD
Losartan—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000719	0.00255	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000703	0.0025	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—FGD1—nicotine dependence	0.000702	0.00249	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—OPRM1—nicotine dependence	0.000639	0.00227	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—CYP2A7—nicotine dependence	0.000639	0.00227	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AKR1B10—nicotine dependence	0.00062	0.0022	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—CYP2A7—nicotine dependence	0.000602	0.00214	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—CYP2A7—nicotine dependence	0.000543	0.00193	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—DRD2—nicotine dependence	0.000508	0.0018	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000493	0.00175	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—DRD2—nicotine dependence	0.000462	0.00164	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CYP2A7—nicotine dependence	0.000441	0.00157	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—WASF2—nicotine dependence	0.000437	0.00155	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000432	0.00153	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—WASF1—nicotine dependence	0.000419	0.00149	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CYP2A7—nicotine dependence	0.000404	0.00144	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—OPRM1—nicotine dependence	0.000377	0.00134	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—DRD2—nicotine dependence	0.000273	0.000968	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000268	0.000952	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.000232	0.000825	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP2A7—nicotine dependence	0.000231	0.00082	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000207	0.000736	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000202	0.000718	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000189	0.000671	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000162	0.000574	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000125	0.000443	CbGpPWpGaD
